Fujisawa Kentoku, Ohkura Yu, Ueno Masaki, Yago Akikazu, Shimoyama Hayato, Udagawa Harushi
Department of Gastroenterological Surgery, Toranomon Hospital, Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
Ann Surg Oncol. 2021 Dec;28(13):8414-8425. doi: 10.1245/s10434-021-10222-8. Epub 2021 Jun 3.
Thoracic duct (TD) resection is performed when the tumor or a metastatic lymph node directly invades the TD, and is sometimes indicated for radical lymphadenectomy during esophagectomy in esophageal cancer patients. However, the effect of TD resection on nutritional status has not been established.
In total, 174 consecutive patients from October 2015 to March 2019 who underwent radical esophagectomy for esophageal cancer in Toranomon Hospital were classified into thoracic duct preserved group (n = 51) and TD-resected (TD-R) group (n = 123). We compared laboratory data, body composition data from bioelectrical impedance analysis measured preoperatively and at 1 and 12 months after surgery, and postoperative complications between the two groups.
Clinical stage was significantly more advanced in the TD-R group. Total body weight, body mass index, and fat mass continuously decreased in the two groups over 12 months after surgery, and the decreases were statistically greater in the TD-R group at 12 months after surgery. Skeletal muscle mass and fat-free mass decreased over 1 month after surgery and stayed in a reduced state until 12 months after surgery without statistically significant differences between the two groups. TD resection did not increase incidence of postoperative complications (Clavien-Dindo classification ≥ grade III), but TD resection increased incidence of chylothorax.
Our results suggest that loss of body fat mass, which was a main contributor to body weight loss, was accelerated in the TD-R group, but TD resection does not deteriorate loss of muscle mass at 12 months after surgery.
当肿瘤或转移性淋巴结直接侵犯胸导管(TD)时需进行胸导管切除术,在食管癌患者行食管切除术时,有时也会因根治性淋巴结清扫而进行该手术。然而,胸导管切除术对营养状况的影响尚未明确。
2015年10月至2019年3月在虎之门医院连续接受食管癌根治性食管切除术的174例患者被分为胸导管保留组(n = 51)和胸导管切除(TD - R)组(n = 123)。我们比较了两组的实验室数据、术前及术后1个月和12个月通过生物电阻抗分析测量的身体成分数据以及术后并发症。
TD - R组的临床分期明显更晚。术后12个月内,两组的总体重、体重指数和脂肪量持续下降,且术后12个月时TD - R组的下降在统计学上更显著。骨骼肌量和去脂体重在术后1个月内下降,并在术后12个月一直处于减少状态,两组之间无统计学显著差异。胸导管切除术并未增加术后并发症(Clavien - Dindo分级≥Ⅲ级)的发生率,但胸导管切除术增加了乳糜胸的发生率。
我们的结果表明,作为体重减轻主要因素的身体脂肪量的减少在TD - R组中加速,但胸导管切除术在术后12个月时并未使肌肉量的减少恶化。